Healthtech & Wellness VC Funds

Bullpen Capital, established in 2010, is a venture capital firm based in San Francisco that specializes in post-seed investments. Their focus is on startups that have found product-market fit but are often overlooked by traditional venture capital due to various factors such as market size or early-stage revenue metrics. Bullpen Capital has funded over 100 companies, leveraging their expertise to help these businesses achieve significant milestones within a short period. Notable investments by Bullpen Capital include companies like FanDuel, Grove Collaborative, and Life360, all of which have achieved notable exits. Other significant portfolio companies include IPSY, Braze, and Carbon Health, reflecting their diverse investment strategy across consumer products, enterprise software, health tech, and more. The team at Bullpen Capital includes experienced professionals like co-founder Paul Martino and partners Eric Wiesen and Richard Melmon. Their combined experience spans across various industries and operational roles, providing portfolio companies with robust support and strategic guidance. Bullpen Capital continues to focus on sectors such as e-commerce, health, and enterprise applications, ensuring their portfolio companies receive the necessary resources and mentorship to scale effectively.

Burnt Island Ventures is a specialized venture capital firm that focuses exclusively on water innovation. Founded by Tom Ferguson, who brings over a decade of experience in the water sector, the firm is committed to finding, funding, and supporting the best entrepreneurs worldwide who are developing groundbreaking water technologies. Unlike broader cleantech funds, Burnt Island Ventures dedicates itself entirely to water, recognizing it as a foundational yet often overlooked market in the global economy. The firm’s investment strategy revolves around early-stage ventures, providing not just capital but also deep sector expertise and an extensive network in the water industry. Burnt Island Ventures operates with the belief that addressing climate change is inseparable from managing water resources, positioning itself as a crucial player in this vital sector. The team includes seasoned professionals like Christine E. Boyle, PhD, a partner with extensive experience in water technology and entrepreneurship, and Steve Kloos, PhD, who has a strong background in water, energy, and venture capital. This diverse team is committed to driving innovation in water management, aiming to tackle the challenges posed by a warming planet​.

Burst Capital is an early-stage venture capital firm founded in 2017 by Geoff Donaker, a former COO of Yelp. The firm is based in Palo Alto, California, and focuses primarily on investing in pre-seed, seed, and Series A rounds, particularly in software, SaaS, fintech, and enterprise sectors. The team includes experienced leaders from Yelp and other major tech companies, offering deep industry knowledge and hands-on support for startups. Burst Capital’s portfolio includes notable companies like Sourcegraph, Handshake, and Ada, with several achieving unicorn status. The firm is known for investing in high-growth tech startups and has been involved in over 120 investments to date. They maintain a lean but experienced team of partners, including Wendy Lim and Rob Krolik, who bring expertise in scaling companies and taking them public. Burst Capital primarily invests in U.S.-based companies but also backs global startups. Their investment strategy is founder-focused, leveraging their operational experience to guide startups from early stages to growth​.

Business Finland is a public organization under the Finnish government that aims to support innovation, economic growth, and sustainable development in Finland. Established in 2018 from a merger between Tekes (the Finnish Funding Agency for Innovation) and Finpro (an export and investment promotion agency), Business Finland offers various services including innovation funding, internationalization support, and investment promotion. Its mission is to accelerate the global success of Finnish companies while positioning Finland as a competitive and attractive destination for foreign investments. Business Finland plays a significant role in promoting Finnish industries globally, particularly focusing on sectors like ICT, cleantech, bioeconomy, health, and digitalization. The organization is also deeply committed to sustainability, which is central to its strategy through 2025. It works to foster collaboration between research institutions, businesses, and international stakeholders, driving systemic change in addressing global challenges like climate change. Additionally, Invest in Finland, a key branch of Business Finland, actively attracts foreign direct investment, helping foreign companies explore opportunities in Finland. This initiative strengthens local ecosystems, creating thousands of jobs annually, particularly in high-growth sectors. With over 760 specialists spread across 40 international locations and 16 offices in Finland, Business Finland remains a cornerstone in fostering innovation and economic development within Finland's vibrant tech ecosystem.

BVP (Business Venture Partners), based in Dublin, is an investment firm focused on supporting innovative companies with a strong emphasis on sustainability and social impact. Their investment portfolio spans sectors like climate technology, health, mobility, and emerging technologies. Notable investments by BVP include Positive Carbon, a company tackling food waste through high-tech sensors and reporting dashboards used in commercial kitchens. The company has clients like the Dalata Hotel Group and Radisson Blu. Another significant investment is in Buymie, a grocery delivery platform that raised €5.8 million in additional funding to expand its operations. BVP has also invested in UFODrive, an all-digital, all-electric car rental service, highlighting their interest in sustainable mobility solutions. BVP provides tailored financial solutions, including equity and debt investments, supporting companies from seed to growth stages. They are also involved in the Employment Investment Incentive Scheme (EIIS) and offer Green Bonds targeting high-impact investments. Overall, BVP is dedicated to fostering companies that not only aim for financial success but also contribute positively to the environment and society.

Butterfly Ventures, established in 2012, is a leading seed-stage venture capital firm based in Helsinki, Finland, with additional offices in Oulu, Stockholm, Tallinn, and Copenhagen. The firm focuses on deep tech and hardware startups in the Nordics and Baltics. Their investment portfolio includes companies such as Wolt and Supercell, showcasing their commitment to backing transformative technology companies. Butterfly Ventures typically invests in pre-seed, seed, and early-stage rounds, with check sizes ranging from €100,000 to €2 million. They emphasize sustainable and science-based innovations, aligning with the EU's Article 8 and Sustainable Finance Disclosure Regulation (SFDR). Their latest fund, Butterfly Venture Fund IV, raised an initial €47 million, aiming for a total of €100 million to support groundbreaking startups across the region. The team at Butterfly Ventures includes experienced professionals like Juho Risku, co-founder and partner, who has a strong background in digital technologies and entrepreneurship. Other key members include Ville Heikkinen, known for his expertise in VC financing and M&A, and Tanya Horowitz, who brings a wealth of experience from her background in asset management and M&A investment banking in New York. Butterfly Ventures is deeply integrated into the Nordic startup ecosystem, actively seeking companies that have the potential for significant societal, environmental, and economic impact. Startups looking to partner with Butterfly Ventures should focus on innovative solutions that address major global challenges, particularly in deep tech and hardware sectors.

Byers Capital, managed by Blake Byers, is a San Francisco-based family office that focuses on early-stage investments in technology and biotech sectors. Founded in 2021, the firm has quickly established a diverse portfolio, including investments in high-profile companies like Neuralink, NewLimit, and Benchling. Byers Capital is known for its strategic investments in Series A and B rounds, particularly in the healthcare and enterprise applications sectors. The firm primarily invests in the United States but has also made select international investments, such as in the Netherlands. Byers Capital leverages Blake Byers' extensive experience as a former partner at Google Ventures, where he was involved in several successful exits, including companies like Robinhood and Grail. This deep expertise in both venture capital and scientific research allows Byers Capital to support its portfolio companies with not just capital, but also strategic guidance and industry connections​.

ByFounders, established in 2017, is a venture capital firm focused on early-stage investments in the Nordic and Baltic regions. The firm, based in Copenhagen and Stockholm, is known for its collective approach, leveraging a network of successful founders and operators to support its portfolio companies. ByFounders targets pre-seed and seed stage startups, particularly those in industries such as fintech, insurtech, AI, and SaaS. Notable investments include companies like SafetyWing, a global social safety net provider; Uizard, which uses machine learning to turn sketches into digital prototypes; and Normative, which provides carbon accounting software. The firm's investment strategy is deeply rooted in its community, known as the byFounders Collective, which consists of over 40 experienced Nordic and Baltic founders and operators. This collective offers portfolio companies operational expertise and a global network, helping them scale internationally. For example, companies like Corti, an AI health tech startup, and Monta, an EV charging management platform, have benefited from this extensive support network. ByFounders has made significant strides in promoting diversity within its investments. Over half of its portfolio companies have diverse founding teams, aligning with their commitment to fostering inclusive growth in the startup ecosystem.

C2 Ventures is an early-stage venture capital firm established in 2014 by Chris Cunningham and Matt Olivo. The firm focuses on investing in companies developing enterprise software and robotics solutions for legacy industries. Their goal is to provide these companies with the necessary capital and strategic support to improve productivity, capital efficiency, and profit margins. Additionally, C2 Ventures has a strong interest in clean-tech and sustainability solutions. C2 Ventures has raised several funds, including C2V Capital Partners I and II, and the Tributary Fund, which targets pre-seed investments. They provide a hands-on approach, assisting portfolio companies with revenue growth, market traction, cash management, and strategic pivots or exits. The firm emphasizes building strong relationships with founders and leveraging the expertise of their extensive network of successful entrepreneurs and tech executives. Their portfolio includes a diverse range of companies such as Paladin, Driver Technologies, OmniX Labs, and Argyle. The team at C2 Ventures brings extensive experience in asset management, startup growth, and operational expertise, ensuring their portfolio companies receive comprehensive support to achieve success.

C4 Ventures is a distinguished European venture capital firm established in 2012 by Pascal Cagni, a former Apple executive, with offices in Paris and London. The firm specializes in early to mid-stage investments in technology-driven startups, particularly those targeting expansion into European markets. C4 Ventures’ impressive portfolio includes notable investments in companies such as Graphcore, Riskified, and Foursquare. They are recognized for their strategic support and capital, which have been pivotal in helping businesses like Anki and Clippings scale successfully. The firm focuses on sectors including consumer hardware, digital media, and e-commerce, with recent investments in innovative companies like VoltR and Refurbed. C4 Ventures typically leads funding rounds and offers hands-on assistance to their portfolio companies, leveraging the extensive industry experience of their team, including co-founder Boris Bakech and partner Michel Sassano. For startups aiming to engage with C4 Ventures, it's essential to demonstrate a clear path to market leadership and scalability. The firm values innovative approaches and strong market potential, evidenced by their active investment and exit strategies, including significant exits like Riskified and Trouva.

C5 Capital is a specialist investment firm focusing on cybersecurity, space, and energy security, with a mission to foster a secure digital future. Their portfolio includes companies like Axiom Space, which is developing the first commercial space station, and RapidSOS, a company revolutionizing emergency response systems. C5 is known for backing high-growth companies within the secure data ecosystem, encompassing sectors such as cloud infrastructure, data analytics, and AI. The firm’s investment strategy emphasizes long-term relationships with mid to late-stage companies, providing not just capital but also strategic growth support, leveraging their strong network of government and private sector partners. Through initiatives like C5 Cyber Partners, the firm focuses on scaling operations, expanding into new geographies, and driving sales growth for its portfolio companies. Additionally, the C5 Space Data Fund targets high-potential technologies impacting global infrastructure. Founded by André Pienaar and operating globally, C5 Capital has a significant presence in both Washington D.C. and London. The team consists of experts with deep domain experience, including former government officials and top-tier industry leaders. Their philanthropic arm, C5 Philanthropy, further supports global security initiatives, including conflict resolution and anti-corruption efforts, aligning with their broader mission to create social impact alongside financial returns.

Cabra VC is a Cyprus-based venture capital firm focused on investing in high-growth, technology-driven startups across the USA, Europe, the Middle East, and Asia. Established in 2016, the firm primarily targets early-stage companies, with a strong preference for those in sectors such as SaaS, fintech, AI, e-commerce, and healthtech. Notably, Cabra VC places a particular emphasis on subscription-based business models, seeking to support companies that can scale rapidly to international markets. Their investment approach spans from seed to Series A and beyond, with Cabra VC often engaging in follow-on investments to ensure long-term growth. The firm’s recent investments include notable startups like Collectly and Spenny, which are part of its diverse portfolio​. Cabra VC is distinguished by its hands-on support in areas like business development, legal guidance, and growth strategy setup, making it a reliable partner for startups looking to scale globally​. The leadership team, including Shukhrat Ibragimov and Alexey Alexanov, brings a wealth of experience from the technology, media, and telecom sectors, further strengthening Cabra VC's capacity to assist its portfolio companies through strategic and operational challenges

Cacao Capital is a family-owned venture capital firm based in Guatemala City, Guatemala, founded in 2019. Named after the Maya tradition of using cacao beans as currency — the cacao tree first cultivated in Central America — the firm invests in startups at the idea, pre-seed, seed, and early stages across fintech, agritech, e-commerce, healthtech, SaaS, ad tech, and food technology sectors. Managing Partner Ximena Matus leads the firm's focus on conscious angel and impact-oriented investment in emerging market entrepreneurs. The portfolio of nine companies includes Influur, a content creator fintech platform, and EA Electric Aviation. The firm's typical check size is below $100,000, targeting early-stage Latin American and emerging market startups with social and economic impact potential. Cacao Capital operates in an underserved segment of Latin American venture — pre-institutional, in a Central American market with limited early-stage capital infrastructure — where a patient, mission-aligned investor can provide meaningful support to founders who have few alternatives at the idea and pre-seed stage. The firm's impact orientation reflects a belief that technology entrepreneurship in emerging markets generates both financial returns and measurable community benefit.

Caerus Ventures was a West Palm Beach, Florida-based early-stage venture capital firm founded in 2011 by Brodi Jackson and Gregory Borchardt. The firm invested in companies operating at the convergence of hardware and software — spanning IoT, computer vision, industrial automation, health and wellness, robotics, transportation, smart home, manufacturing, retail, logistics, agritech, insurance tech, construction, and smart cities. Caerus focused on seed and early growth-stage startups with demonstrated traction in connected hardware and software solutions, deploying $100,000 to $2 million per investment. The firm is now permanently closed. The portfolio of 13 investments included Dash (automotive IoT), Socure (identity verification, which subsequently became a major fintech company with widespread adoption across financial institutions), and Kairos (facial recognition AI). Partner Sarah Hassan rounded out the founding team. Caerus operated at a time when the hardware-software convergence was transitioning from early adopter curiosity to enterprise-grade production deployment. Caerus Ventures built its thesis around the observation that the most defensible technology companies in the IoT era would be those combining purpose-built hardware with proprietary software — creating data advantages and switching costs that pure software competitors could not replicate. The firm's portfolio reflected a disciplined application of that framework across multiple vertical markets.

Caffeinated Capital is an early-stage venture capital firm founded in 2013 by Raymond Tonsing and based in San Francisco, California. The firm focuses on investing in transformative technology companies from inception and supporting them throughout their growth stages. Caffeinated Capital has a diversified portfolio across sectors such as consumer, healthcare, fintech, defense, and cryptocurrency. Notable investments include companies like Affirm, Pluto, and Gigster, with exits such as Zoox (acquired by Amazon) and CTRL-Labs (acquired by Meta). The firm has a strong track record of backing successful startups that later attract significant follow-on funding from other major investors. Caffeinated Capital typically invests in pre-seed, seed, and Series A rounds, with an average check size ranging from $2 million to $12 million. The firm is highly selective, often partnering with founders who demonstrate a unique vision and the resilience to bring transformative ideas to fruition. The team at Caffeinated Capital, led by Raymond Tonsing, is known for its hands-on approach, providing strategic guidance, mentorship, and leveraging its extensive network to support portfolio companies. The firm has a global investment outlook but maintains a strong presence in major US tech hubs, particularly San Francisco.

Caixa Capital Risc, established in 2004 and based in Barcelona, Spain, is the venture capital arm of CriteriaCaixa. The firm focuses on investing in innovative companies at their initial and growth stages, particularly in Spain and Portugal. Caixa Capital Risc specializes in three main areas: Information Technology, Life Sciences, and Industrial Technologies. The firm typically invests in rounds ranging from pre-seed to Series B, with investment amounts varying from $500,000 to $5 million. Notable sectors they invest in include analytics, AI, cloud infrastructure, developer tools, edtech, fintech, healthcare services, and robotics. Their extensive portfolio includes companies like Build38, MedLumics, and Recognai, showcasing their diverse investment interests. Caixa Capital Risc is committed to supporting its portfolio companies not only financially but also through strategic guidance and leveraging its extensive network. They have a history of successful exits and are considered a key player in the Spanish and Portuguese startup ecosystems.

Cake Ventures, founded by Monique Woodard, is a venture capital firm that focuses on investing in early-stage companies poised to capitalize on significant demographic shifts. Woodard's investment strategy is built around three key areas: aging and longevity, the increasing spending power of women, and the rise of a new majority as people of color become the fastest-growing consumer groups in the U.S. With a $17 million fund, Cake Ventures primarily invests in pre-seed and seed-stage companies, typically writing checks between $200K and $750K. The firm is committed to supporting startups that address the needs of tomorrow's internet users, particularly those influenced by demographic changes. This includes companies like Mama Foods, a grocery delivery service for the U.S. Latino community, and Guaranteed, a company reimagining hospice care. Woodard's approach is unique in the venture capital landscape, as she emphasizes not just the business potential but also the social impact of these demographic trends. Her firm has backed 12 companies so far, with a significant portion led by women.

Calculus Capital, founded in 1999 by John Glencross and Susan McDonald, is a UK-based venture capital firm focusing on Enterprise Investment Schemes (EIS) and Venture Capital Trusts (VCT). The firm invests in early-stage companies in high-growth sectors such as technology, healthcare, and entertainment. The Calculus VCT offers a diversified portfolio of 30-40 UK companies, providing development and scale-up capital. Investors benefit from tax-efficient opportunities, including 30% income tax relief and tax-free capital gains and dividends if shares are held for at least five years. The Calculus EIS Fund targets Knowledge Intensive Companies, offering similar tax benefits and aiming for a return of £2 for every £1 invested. Calculus Capital is known for its strategic, hands-on approach, supporting companies with strong business models and significant growth potential. The firm's experienced team from leading financial institutions ensures robust support and guidance, contributing to successful exits like those to Microsoft and SAP.

Calibrate Ventures is a Pasadena-based venture capital firm founded in 2017, specializing in early-stage investments in deep tech, AI, and automation. The firm supports technical founders who are developing transformative technologies in sectors such as logistics, manufacturing, and healthcare. Calibrate focuses on companies generating under $5 million in recurring revenue, providing hands-on guidance during the critical scaling phase. Their portfolio includes innovative companies like FarmWise (AI-enabled agricultural technology), GrayMatter Robotics (automation for manufacturing), and aiXplain (no-code AI development). Calibrate invests in solutions that address major market needs and are ready to scale across industries such as transportation, food production, and healthcare. Led by co-founders Jason Schoettler and Kevin Dunlap, Calibrate has raised two funds to date and is actively helping build the next generation of AI and automation leaders. The firm has seen notable exits, including the acquisition of TruckLabs in 2023 following a period of significant revenue growth. In addition to investing, Calibrate organizes industry events like Edge of Now (EON), bringing together leading minds in AI to foster collaboration and explore future innovations. Calibrate Ventures’ focus on deep tech and its ability to partner closely with founders allows it to be a key player in driving the next wave of industrial transformation through AI and robotics.

The California Health Care Foundation's (CHCF) Innovation Fund is a venture arm that invests in early- and growth-stage companies focused on improving healthcare access, quality, and equity for underserved populations in California. The fund targets innovative startups that align with CHCF's mission to enhance care in the safety net, especially for low-income individuals and communities of color. CHCF typically makes investments ranging from $50,000 to $1 million, with an emphasis on tech-enabled healthcare solutions. Notable portfolio companies include Motivo Health, which connects aspiring therapists to clinical supervisors, and Twentyeight Health, offering telehealth services for reproductive care in underserved communities. The fund also supports RubiconMD, a platform that facilitates specialist e-consults for primary care providers. The Innovation Fund stands out by focusing on social impact over financial returns, blending program-related investments with grant support to scale solutions across California. They actively seek diverse founders, particularly from Black, Latinx, and female-led ventures, aiming to close gaps in traditional venture capital access. Startups can contact the fund directly, with a preference for those that already have clients or partnerships within the state.

Calm/Storm Ventures, based in Vienna, Austria, is a boutique venture capital firm and exclusive founder network that focuses on early-stage investments in digital health and wellbeing startups. The firm is known for its emphasis on purpose-driven founders who aim to improve life, health, and wellbeing. Calm/Storm Ventures has a distinctive track record of investing in projects that address sensitive and often overlooked areas such as infertility, sexual wellness, mental health, and chronic conditions. Founded in 2020, Calm/Storm Ventures targets super-early stage companies, including pre-seed, seed, and (pre-)Series A rounds. The firm has built a diverse portfolio with investments in companies like Biloba, an instant messaging app for pediatric consultations; Healee, a digital health platform for telehealth services; and Thymia, which aims to make mental health objectively measurable. The investment team at Calm/Storm is composed of founders and entrepreneurs who bring extensive experience and a hands-on approach to supporting portfolio companies. The team includes Lucanus Polagnoli as Founding Partner and CEO, Philippa Allen as Junior Investment Manager, and Johannes Blaschke as Principal. The firm also boasts a high level of diversity, with 50% of its portfolio companies having diverse teams, and 60% of its board members being female. Calm/Storm Ventures is not only a capital provider but also offers deep expertise in business development, market positioning, and global connectivity, helping startups navigate the complexities of the healthcare and wellbeing sectors.

Cambridge Angels, established in 2001, is a prominent UK business angel network based in Cambridge. The group comprises over 60 affluent investors who provide smart capital and mentorship to startups and scale-ups primarily in the UK, focusing on science, engineering, and healthcare technology sectors. They have invested over £150 million in more than 120 companies. Notable investments by Cambridge Angels include companies like Paragraf, Arecor, Eagle Genomics, Privitar, and Healx. The group supports these companies not just financially, with typical investments ranging from £150,000 to £1.5 million, but also through strategic guidance, leveraging their extensive experience as successful entrepreneurs. Cambridge Angels is known for their commitment to fostering innovation without charging founders to pitch, ensuring that the entrepreneurial focus remains on development and growth. This investor group also holds educational sessions for portfolio companies, covering critical topics such as exit strategies and leadership development.

Cambridge Innovation Capital (CIC) is a venture capital firm based in Cambridge, UK, specializing in investing in deeptech and life sciences startups. Established to leverage the rich innovation ecosystem around the University of Cambridge, CIC manages over £500 million across its funds, focusing on supporting early to growth-stage companies. The firm plays a strategic role in fostering innovation by backing ventures that emerge from the Cambridge cluster, including university spinouts and collaborations with research institutes like the Wellcome Sanger Institute. CIC's investment portfolio reflects its emphasis on groundbreaking technology, with companies like CMR Surgical, known for its Versius robotic surgery system, and PragmatIC Semiconductor, which focuses on flexible electronics. The firm also invests in biotech firms like Microbiotica, which leverages the microbiome for therapeutic purposes, and quantum computing ventures such as Riverlane. With its commitment to sustainability and a robust focus on ESG (Environmental, Social, and Governance), CIC aims to create long-term value while fostering responsible business practices. The firm not only provides capital but also strategic support, often co-investing alongside other prominent funds and facilitating connections through initiatives like DeepTech Labs and Start Codon, two accelerators designed to help startups navigate early commercial challenges. Led by Managing Partner Andrew Williamson, CIC remains deeply integrated within the Cambridge ecosystem, collaborating with universities, research hubs, and industry leaders to drive the next wave of technological breakthroughs​.

Camelback Ventures is a venture accelerator and impact fund based in New Orleans, Louisiana, founded in 2015. The organization increases access to opportunity for entrepreneurs of color and women by investing in their ventures, developing their leadership, and advocating for systemic fairness in funding. Named after the camelback-style homes built by Free Black families in New Orleans after the Civil War, the firm invests $50,000 per company through its Camelback Fellowship — as SAFE notes for for-profits and grants for nonprofits — alongside coaching, connections, and curriculum. Since 2015, Camelback has directly invested $5 million and provided $5 million in additional coaching and resources to more than 220 entrepreneurs across 130-plus fellows. Fellows have collectively raised over $109 million in follow-on funding. Ninety-four percent of fellows identify as Black, Indigenous, or people of color; 63% identify as women or non-binary. Focus areas are education and conscious technology addressing systemic inequity, with the portfolio spanning education, software, health, and fintech. Fellows have been recognized in Forbes 30 Under 30, Echoing Green, and Richard Draper Kaplan fellowships. CEO Shawna Young leads the organization. Camelback's thesis holds that talent is evenly distributed but opportunity is not — and that pre-seed capital, paired with intensive mentorship and community, can unlock a generation of founders whose ventures address gaps in education and social infrastructure while building financially sustainable businesses.

Camelot Venture Group is a private investment group based in West Palm Beach, Florida, founded in 1999. The firm invests in direct-to-consumer businesses spanning e-commerce, catalog retail, technology, financial services, and sports management, providing growth capital alongside hands-on operational expertise and strategic guidance. Led by Managing Partner David Katzman together with partners Steve Katzman, Steve Cicurel, and Nicholas Pyett, the team has built a portfolio of 18 companies, with a particular concentration in B2C and marketplace models. Camelot leads rounds at the Series A through Series C stages, writing checks averaging $10 million per deal. The firm's most prominent portfolio achievement is SmileDirectClub, which completed its NASDAQ IPO in September 2019. Across its 18 investments, the firm has recorded five portfolio exits, reflecting a disciplined focus on consumer-facing businesses where the partnership can apply direct operational and strategic value. The firm's investment philosophy is grounded in operational partnership rather than passive capital deployment. Camelot selects businesses where its team can contribute meaningfully to execution — helping companies refine go-to-market approaches, improve unit economics, and scale customer acquisition. This founder-aligned model positions Camelot as a true operating partner for consumer entrepreneurs building category-leading businesses across the United States.

Camford Capital is a Palo Alto-based venture capital firm that focuses on investing in transformative technologies across sectors like enterprise software, consumer products, fintech, and healthcare. Founded in 2021, the firm partners with early-stage and growth-stage companies in the U.S. and Asia, seeking to back innovative solutions that have the potential to reshape industries globally. Camford has built a strong portfolio that includes notable investments such as CG Oncology and Totus Medicines, which highlight its emphasis on life sciences. Additionally, the firm has backed Viz.ai an AI-driven healthcare company, and Stori, a fintech unicorn offering credit card solutions in Latin America. The firm is particularly known for its ability to identify and support companies that leverage exponential technologies to tackle complex problems in healthcare and financial services. The leadership team at Camford consists of experienced entrepreneurs and investors, including Andrew Gu and Ali Farahanchi, who bring deep operational and investment expertise. Their strategy combines hands-on partnership with founders and an ability to co-invest with global players like General Catalyst and Khosla Ventures. Camford Capital tends to invest anywhere between $500,000 and $10 million, with a preference for leading funding rounds. Entrepreneurs seeking investment can reach out to the firm through its website for inquiries.

Canaan is a leading early-stage venture capital firm that focuses on transformative ideas in the technology and healthcare sectors. With a strong history spanning over 35 years, Canaan has invested in notable companies such as Instacart, LendingClub, The RealReal, and Match.com. The firm has managed to achieve impressive exits, including IPOs for companies like TheRealReal, Arvinas, and Day One Biopharmaceuticals. Canaan’s investment strategy covers a wide range of industries including enterprise software, consumer tech, fintech, and frontier tech. They are particularly noted for their deep involvement in healthcare, with significant investments in areas such as oncology, immunology, and neurology. Their portfolio includes companies like Dexcom, Synthekine, and Vivace Therapeutics, among others. The firm manages over $6.8 billion in assets and recently closed its thirteenth fund with $850 million to continue supporting innovative startups through their early and growth stages. This new capital will help expand their investments in robotics, AI/ML, cybersecurity, and genetically defined precision medicines​.

Canbank Venture Capital Fund (CVCF) is India's first and only public sector bank-sponsored venture fund, established on October 21, 1989 by Canara Bank as a trust. Headquartered in Bangalore, the Investment Manager — Canbank Venture Capital Fund Limited — is a wholly owned subsidiary of Canara Bank. Over more than three decades, CVCFL has managed six direct venture capital funds with a combined corpus of INR 790 crore, plus the Electronics Development Fund with an additional INR 927 crore corpus, bringing total funds under management to over INR 1,000 crore (approximately $120 million). The firm invests across Seed through Series B stages, with typical checks of $500,000 to $3 million. The portfolio encompasses 100-plus investments across 40 active companies, spanning software, fintech, AI and deep tech, healthtech, hardware and robotics, cleantech, education, and agritech. A team of 17 professionals — including eight partners and seven principals — evaluates opportunities against a standard of established technological or market positioning edges with strong growth potential. As a pioneering institution in India's venture ecosystem, Canbank Venture Capital Fund has played a structurally important role in channeling public sector capital toward innovation. The firm maintains high standards of governance and transparency, generating risk-adjusted returns while supporting the development of technology-driven businesses that align with India's broader industrial and economic priorities.

Cantos Ventures, established in 2016 and headquartered in San Francisco, focuses on pre-seed and seed-stage investments in frontier technologies. The firm invests in sectors such as climate tech, computational biology, aerospace, and advanced computing. Notable companies in their portfolio include Solugen, Astranis, and Public, reflecting their commitment to transformative technologies. Cantos Ventures emphasizes investing in high-potential startups tackling significant global challenges. Recent investments include Furno Materials, which raised $6.5 million for decarbonizing cement production, and Shinkei Systems, which secured $6.27 million to innovate in sustainable fish processing. The firm collaborates with co-investors like Y Combinator and 8VC, ensuring a robust support network for their portfolio companies. The team at Cantos Ventures, led by Ian Rountree and Natalie Estrella, leverages extensive experience to support founders. They adopt a hands-on approach, providing strategic guidance and access to global networks. Startups seeking investment should demonstrate strong technical capabilities and a clear vision for addressing large-scale problems. Cantos Ventures is recognized for its selective and impactful investment strategy, often leading rounds with substantial financial commitments to drive growth and innovation

Canvas Ventures is a Portola Valley-based venture capital firm founded in 2013 by Rebecca Lynn, Gary Little, and Paul Hsiao. Specializing in Series A and B investments, Canvas Ventures primarily focuses on fintech, digital health, AI, marketplaces, and logistics sectors. With a strategic emphasis on companies poised for significant growth, the firm offers more than just capital, providing extensive go-to-market expertise, sales strategy, and growth guidance to their portfolio companies. Notable investments include Luminar Technologies, which went public via SPAC in 2020, and successful ventures like Zola, Vida Health, and Transfix. Their recent fund, CV3, raised $350 million, bringing their total capital raised to $835 million. Canvas typically leads funding rounds with investments ranging from $5 million to $15 million. The firm is led by experienced partners, including Rebecca Lynn, a renowned investor with deep expertise in consumer credit and healthtech. Canvas Ventures has a mission-driven approach, deeply engaging with their portfolio companies to ensure their success. The team has also established the Canvas GTM Council, comprising top marketing and sales professionals who provide invaluable insights to portfolio companies. Canvas Ventures prefers to work with founders who are tackling transformative problems and are prepared for the long-term journey of building significant companies. They maintain a collaborative and supportive relationship with entrepreneurs, helping them navigate challenges and scale their businesses effectively.

CapHorn Invest is a Paris-based venture capital firm established in 2011, focusing on early to growth-stage investments in sectors such as climatetech, healthtech, and enterprise software. The firm typically invests between €1 million and €15 million, targeting startups that offer high-growth potential and innovative solutions across Europe. CapHorn is part of the Anaxago Group, aligning its investment strategy with the goal of driving sustainable innovation and impact. CapHorn supports startups with not just capital but also strategic guidance, leveraging its network of business leaders and experts to accelerate growth. The firm has backed notable companies such as Tilak Healthcare, Finalcad, and InterCloud, all of which align with its focus on transformative B2B solutions. The firm’s investment strategy is built around fostering companies that address critical societal challenges, such as sustainability and technological advancements in healthcare and digital infrastructure. CapHorn primarily focuses on Series A to Series C funding rounds, partnering with exceptional entrepreneurs to help them scale their businesses both in France and internationally. The leadership team at CapHorn includes experienced venture capitalists and industry experts, ensuring that startups receive hands-on support throughout their growth journey. With over €200 million in assets under management, CapHorn remains a key player in the European VC landscape, committed to driving innovation across its target sectors.

Capagro is a Paris-based venture capital firm established in 2014, focusing on investments in the AgTech and FoodTech sectors. The firm aims to accelerate innovation and development across the agricultural and food value chains, supporting companies that offer sustainable and impactful solutions. Capagro's portfolio includes notable companies such as Naïo Technologies, which develops agricultural robotics, Cuure, a personalized health and wellness provider, and NICK'S, a snack food manufacturer. Other significant investments are in La Belle Vie, an e-commerce grocery platform, and ecoRobotix, which specializes in precision farming robotics. The firm typically invests between €1 million and €5 million per round, emphasizing early-growth companies that already have significant revenues or are close to commercialization. Capagro has made 36 investments to date, with a strategy focusing on three main segments: upstream agricultural production, downstream consumer food products, and energy efficiency innovations in the agro-industrial sector. Capagro is led by Jean-Baptiste Cuisinier and Jérôme Samson, who bring extensive experience in food, agribusiness, and venture capital. Their deep industry knowledge and strategic support have made Capagro a valuable partner for innovative startups aiming to scale and make a global impact. The firm manages assets of approximately €124 million, backed by notable investors including Bpifrance and Groupe Avril. Capagro continues to seek new investment opportunities to bridge the funding gap in the European AgTech and FoodTech industries.

Capital Factory is a prominent venture capital firm and accelerator based in Austin, Texas, that serves as a major hub for entrepreneurs across Texas. Founded in 2009, it supports early-stage tech startups through investments, mentorship, and community access. Its program emphasizes long-term engagement, providing startups with free coworking space, extensive mentorship from industry leaders, and introductions to investors. Capital Factory stands out with its robust network, which includes hundreds of mentors and partnerships with major tech companies like Amazon and Google, offering hosting credits and other resources to its portfolio companies. Capital Factory’s accelerator is not your typical boot camp. Instead, startups can immerse themselves in the program, gaining the support needed to scale, with Capital Factory taking a 1% equity stake. The firm is particularly active in sectors like artificial intelligence, digital health, education technology, and SaaS, making investments in companies such as Zen Business and Aceable. Beyond its Austin headquarters, Capital Factory has expanded its influence with programs in Dallas, Houston, and San Antonio, making it a central player in the Texas startup ecosystem.

Capital Medica Ventures (CMV) is a venture capital firm based in Tokyo, Japan, focusing on early-stage investments within the healthcare sector. Established in 2016, CMV emphasizes impact investing, targeting startups that address significant social challenges related to healthcare and wellness. Its mission is to be a supportive partner, guiding entrepreneurs who are driving change through innovative solutions. CMV operates several funds, including the "Healthcare New Frontier Fund," which invests in companies with the potential to create substantial outcomes for customers by improving their health and quality of life. The firm’s investment approach is deeply rooted in Impact Management and Measurement (IMM), which ensures that financial support is aligned with generating measurable social impact. CMV typically invests between ¥5 million to several hundred million yen per round, with follow-on funding based on the startup’s growth trajectory. Notable portfolio companies include Emimen, which recently achieved an IPO on the Tokyo Stock Exchange’s growth market, showcasing CMV's ability to nurture and scale promising ventures. CMV manages a variety of specialized funds, such as the Tokyo Wellness Impact Fund, which supports startups in wellness across sectors like healthcare, elderly care, and fitness. Additionally, the firm collaborates with other institutions like Nanto Bank to expand its reach into regional projects through the Yamato Social Impact Fund, focusing on broader areas such as agriculture, education, and cultural preservation. Led by CEO Takeshi Aoki, CMV combines strategic expertise with a commitment to sustainable, impact-driven growth, positioning itself as a leader in Japan’s healthcare venture capital space.

Capnamic Ventures, based in Cologne and Berlin, is a premier early-stage venture capital firm with a strong focus on technology startups in German-speaking countries. They support companies from Pre-Seed to Series A, specializing in the critical early decisions that shape a startup's trajectory. Their portfolio boasts notable investments like LeanIX, Adjust, and CrossEngage, with successful exits demonstrating their strategic acumen. Capnamic’s investment strategy emphasizes hands-on support, leveraging their extensive industry network and resources to help startups with everything from setting up financial departments to making executive hires. They pride themselves on being sparring partners to their founders, offering honest, empathetic advice and remaining steadfast supporters through all stages of growth. Led by Managing Partners Christian Siegele, Jörg Binnenbrücker, and Olaf Jacobi, Capnamic brings together a wealth of experience and a robust network of over 100 Limited Partners. Their focus on the German tech scene is complemented by selective international investments, ensuring a deep-rooted connection with local entrepreneurs while remaining open to global opportunities​.

Capricorn Partners, headquartered in Leuven, Belgium, is a leading independent manager of venture capital, growth capital, and quoted equity funds. The firm focuses on innovative companies that leverage technology as a competitive advantage, particularly in sectors such as digital technologies, health, and cleantech. Capricorn Partners manages several funds, including the Capricorn Cleantech Fund, Capricorn Digital Growth Fund, Capricorn Health-Tech Fund, and Capricorn Fusion Fund, which targets opportunities with a specific China strategy. They also manage Quest for Growth, integrating both quoted and private investments, focusing on European companies expected to produce higher than average growth in digital, health, and clean technologies. The firm has a strong commitment to ESG principles and aims to create both financial return and strategic value for its clients. Their investment philosophy is rooted in supporting innovative sectors that drive positive change, making them a pivotal player in the venture capital landscape. Capricorn’s team comprises experienced investment managers with deep technology expertise and broad industrial experience. They offer a unique mix of technology and investment expertise, creating an ecosystem that supports superior returns through the combination of investable capital, innovative ideas, capable entrepreneurship, and business management. For entrepreneurs, Capricorn Partners provides not only capital but also strategic guidance and support, leveraging their extensive network and industry knowledge to foster growth and innovation in their portfolio companies​.

Carao Ventures is an early-stage venture capital firm based in San José, Costa Rica, founded in 2012 by Allan Boruchowicz and Adrian Garcia. It was the first VC firm in Central America and has since become a leading investor across small and medium-sized Latin American markets including Costa Rica, Guatemala, Honduras, Panama, the Dominican Republic, Colombia, Ecuador, and Peru. The firm manages $35 million through Carao Ventures Fund I, launched in July 2021 with a $3 million commitment from IFC (World Bank Group) — the first such Startup Catalyst investment in Central America. Carao leads rounds at the Pre-seed through Series A stages, with typical checks of $500,000 to $1 million across 35 portfolio companies and 64 total investments. Notable portfolio companies include Saf.money in financial software, Crabi in automotive insurance, Strike Security in cybersecurity, and Aviva. The firm has recorded two exits: Logysto, acquired by Clicoh in October 2022, and Megabite in March 2024. Carao's model uniquely combines venture capital investment, venture building, and accelerator practices tailored for frontier Latin American markets. Managing Partner Allan Boruchowicz leads a team of seven alongside partners Tomas Arias, Maria Cristina Oreamuno, and Conrad Kopper. Strategic partnerships with Newtopia VC and Caricaco strengthen the Central American startup ecosystem around the firm. Beyond capital, Carao is a hands-on institutional presence where few others operate.

Carbono3 Ventures is an impact-focused venture capital firm founded in 2018 by Carlos Domínguez Rullán and based in San Juan, Puerto Rico. The firm advises, supports, and invests in impact-driven companies across Latin America and Spain, operating across 11 countries including Mexico, Ecuador, Colombia, Argentina, Peru, Bolivia, Guatemala, and Uruguay. Carbono3 has supported over 60 startups and helped them raise $22 million in aggregate capital. The firm invests primarily at the Pre-seed and Seed stages, with typical checks of $100,000 to $500,000, using direct investments, specialized funds, and SPVs on standard terms of 2.5% management fee over four years and 20% carried interest. Notable portfolio companies include TuBanc in fintech and Wealth2B, alongside pharma investments such as MBQ Pharma. The firm also managed a $7 million fund from the Ricky Martin Foundation focused on Puerto Rico's post-hurricane recovery — targeting affordable housing and renewable energy — and launched C3 Lab with $2.5 million in CDBG-DR federal funding. Carbono3 specifically targets Hispanic founders globally and companies with operations across Latin America and Spain, with a pronounced emphasis on fintech, climatetech, deep tech, and health and wellness sectors. Founder Carlos Domínguez Rullán leads alongside COO Luis Baz, bringing a mission-driven lens that treats environmental sustainability and social impact as investment criteria rather than secondary considerations.

Cardumen Capital, founded in 2017, is a venture capital firm with offices in Tel Aviv and Madrid. It specializes in early-stage investments in deep tech sectors, including AI, cybersecurity, big data, and information technologies. The firm recently raised $120 million for its second deep tech fund, which will focus on pre-seed and seed-stage companies. This brings Cardumen's total assets under management to approximately $225 million. Cardumen Capital's portfolio includes notable investments in companies such as SaaS cybersecurity platform DoControl, big data platform IVIX, and AI hardware company NeuReality. The firm is dedicated to supporting visionary founders and transforming the tech landscape through high-conviction investments.

Carduso Capital is a Groningen-based venture capital firm focused on supporting innovative technology companies, particularly those linked to the University of Groningen and the University Medical Center Groningen. The fund targets sectors such as life sciences, energy, and sustainability, with a special interest in spin-offs and startups leveraging university research. Carduso Capital’s investments range from €100,000 to €5 million, covering companies at various stages of growth, from seed to expansion phases. In addition to financial backing, Carduso takes an active role in providing strategic and managerial support to its portfolio companies, ensuring they have the resources and guidance needed to thrive. Their investment strategy emphasizes long-term collaboration and supports multiple financing rounds if necessary. The fund looks for businesses with completed proof-of-concept and functional prototypes that are nearing market readiness. Portfolio companies must address unmet needs with clear, realistic market-entry strategies. Some notable investments include Ivy Medical, Qdi Systems, and ViroTact, reflecting their focus on high-potential technologies within their core sectors. Led by fund managers Koos Koops, Robert Polano, and Frits Kok, Carduso Capital combines deep industry knowledge with a strong network, enabling startups to benefit from both financial and operational expertise. The team prioritizes fostering long-term success, even during challenging periods, and is deeply involved in ensuring the sustainable growth of its companies. Their active engagement and sector-specific focus make them a valuable partner for tech-driven startups seeking strategic and financial support.

Carnrite Ventures is the venture capital arm of the Carnrite Group, founded in 2015 and headquartered in Houston, Texas. With approximately $25 million in assets under management, the firm partners with entrepreneurs building transformative companies in energy, climate technology, and healthcare technology. The firm was built by operators: Founder and Managing Partner Alan Carnrite leads alongside Jeffrey Carnrite, who joined in 2020 and oversees deal sourcing, due diligence, and portfolio management. Carnrite leads rounds from Pre-seed through Series B, deploying checks of $100,000 to $2 million across 65 investments in energy, cleantech, healthtech, and biotech. The portfolio has produced 17 exits over the firm's decade of investing. Notable portfolio companies include Haven in energy storage, Wheeler Bio in biotechnology, and Nest Collaborative, a healthcare and lactation services platform that raised a Series A in January 2024. The most recent investment was in RBL LLC, a biotech venture creation studio, in September 2025. Beyond capital, Carnrite provides executive leadership, turnaround services, and back-office operational support to portfolio companies — reflecting roots as an operator-first organization rather than a conventional financial investor. Situated at the heart of Houston's energy ecosystem, the firm maintains strong ties to the traditional and emerging energy sector, giving portfolio companies direct access to an industry network that spans major operators, corporates, and technical experts across the Texas energy corridor.

Caruso Ventures, based in Boulder, Colorado, is a venture capital firm focused on investing in tech-enabled companies led by effective CEOs. The firm typically makes initial investments ranging from $500,000 to $1 million during the early revenue ramp stage, with the capacity to lead or follow in subsequent rounds. Caruso Ventures is industry-agnostic, focusing mainly on companies headquartered in the Rocky Mountain Region or affiliated with Endeavor Global. Founded by Dan Caruso and his wife Cindy in 2020, the firm leverages Dan’s extensive experience in scaling fiber networks, including his leadership roles at Zayo Group Holdings, Level 3 Communications, and MFS Communications. Dan has a track record of leading companies to significant exits, such as the $8.5 billion equity exit of Zayo Group. Caruso Ventures also sets up Special Purpose Vehicles (SPVs) for its investments, allowing additional investors to participate in select opportunities. The firm’s mission includes supporting high-impact scaleups and fostering the next generation of entrepreneurial leaders.

Casdin Capital, established in 2012 by Eli Casdin, is a New York-based venture capital firm with a focus on life sciences and healthcare. The firm specializes in investing in companies that are at the forefront of scientific and technological advancements in areas such as molecular medicine, biotechnology, genomics, and synthetic biology. Notable investments by Casdin Capital include high-impact companies like 23andMe, Adaptive Biotechnologies, Recursion Pharmaceuticals, and Ginkgo Bioworks. These investments highlight the firm’s commitment to transformative technologies in health care, gene editing, and diagnostic platforms. Casdin Capital's strategy revolves around funding companies that leverage data and precision-based therapies to revolutionize the healthcare industry. They focus on early-stage to late-stage investments, providing substantial financial support to help these companies scale and achieve significant milestones. The firm has managed to build a robust portfolio with 250 investments and 87 exits, demonstrating a strong track record of successful investments and strategic exits. Key team members include Eli Casdin as the Founder and Chief Investment Officer, Alexandria Fisk as Chief Operating Officer, and Lawrence Canzoneri as Chief Financial Officer. The team’s expertise and deep industry knowledge enable them to identify and support innovative startups effectively. Casdin Capital's approach combines strategic investments with deep sector expertise, positioning them as a leading player in the life sciences investment landscape, actively supporting companies that are poised to make groundbreaking advancements in health and biotechnology.

Castle Island Ventures is an early-stage venture capital firm based in Boston, Massachusetts, focused exclusively on public blockchain investments. Founded in 2018 by Nic Carter and Matt Walsh, the firm supports startups building the infrastructure and applications necessary for the future of decentralized networks. Their mission is to invest in transformative blockchain-based projects that can help realize the full potential of public blockchains. With a portfolio that includes companies like Bitwise, a leading crypto index fund manager, and Arcade, a platform for NFT finance, Castle Island Ventures is deeply embedded in the Web3 and blockchain ecosystem​. They primarily invest in pre-seed and seed rounds, offering checks from $500K to $10M, focusing on three core themes: monetary networks, financial services, and internet architecture​. Castle Island Ventures recently launched its third fund, raising $250 million to back innovative projects in public blockchains. This new fund allows them to continue supporting the shift toward decentralized, rules-based monetary systems, programmable financial services, and Web3 applications​. The firm’s investment team includes general partners Nic Carter, Sean Judge, and Ria Bhutoria, all of whom bring extensive experience in the blockchain and financial sectors​.

AVG Funds, also known as Alumni Ventures Group, is a prominent venture capital firm that leverages the power of alumni networks to invest in innovative startups across various sectors. Founded with the mission to democratize venture capital, AVG Funds has become one of the most active venture firms globally. They manage over $200 million in assets and have made more than 115 investments in the past year alone. AVG Funds focuses on diverse industries, including AI and machine learning, health tech, fintech, cleantech, and cybersecurity. Notable investments include companies like Adventr, a media and information services platform, and Eclypsium, which specializes in cybersecurity for enterprise hardware. Their portfolio also features startups like PartySlate, a digital platform for event planning, and Venus Aerospace, a company developing high-speed transport technologies. The firm operates through a network of alumni funds associated with top universities such as Harvard, MIT, Stanford, and Yale. This structure enables AVG to tap into a vast network of alumni entrepreneurs and investors, providing a rich source of deal flow and support for portfolio companies. AVG Funds typically invests in early to growth-stage companies, with check sizes ranging from $100,000 to $2 million. They emphasize a hands-on approach, providing not only capital but also strategic guidance and connections to help startups scale and succeed.

Catalio Capital Management is a multi-strategy investment firm focused on breakthrough biomedical technology and innovative healthcare companies. Founded in 2020 by George Petrocheilos and Dr. Jacob Vogelstein, Catalio specializes in private equity, private credit, and public equities strategies, supporting companies from inception through to IPO or acquisition. The firm’s portfolio includes notable companies such as Affini-T, which is developing precision T-cell therapeutics for solid tumors, and Boost Neuroscience, focusing on therapies to combat cognitive aging and neurodegeneration. Catalio has also invested in companies like Octant, Inc., and Pheast Therapeutics, demonstrating a strong commitment to advancing precision medicines and novel cancer therapies. Catalio's strategy involves close collaboration with their portfolio companies, leveraging a network of over 36 world-renowned scientists to identify and invest in cutting-edge biomedical technologies. This approach has led to successful investments in companies like Thrive Earlier Detection, which was acquired by EXACT Sciences for $2.15 billion, and Personal Genome Diagnostics, acquired by LabCorp for $500 million.

Catalyst Health Ventures (CHV) is a Boston-based venture capital firm founded in 2000, exclusively focused on innovative early-stage MedTech companies. With over two decades dedicated to the healthcare sector, the firm invests in visionary teams developing breakthrough medical technologies that address significant global unmet clinical needs. The team comprises 13 members including three partners and one venture partner, operating from its office at 129 South Street in Boston. CHV leads rounds at the Seed and Series A stages, writing checks of $1 million to $5 million with continued participation in follow-on rounds through exit. Across 80 investments, the firm has recorded 12 portfolio exits — including acquisitions by Boston Scientific, Veracyte, Agilent Technologies, Life Technologies, and W.L. Gore & Associates, as well as Sera Prognostics' NASDAQ IPO. Key focus areas include oncology, cardiovascular disease, obesity, and women's health, spanning therapeutic devices, diagnostics, drug delivery, and digital health. Recent investments include Conformal Medical, Esperto Medical, Venova Medical, and Aria CV. CHV brings strategic insight, deep industry expertise, and a hands-on collaborative approach to every portfolio relationship. The firm's particular strength lies in helping founders navigate the distinctive regulatory and commercialization complexities of the medical device and diagnostics landscape — a path that requires far more than capital. That specialization, sustained consistently over 25 years, has made Catalyst Health Ventures one of the most experienced dedicated MedTech investors in the United States.

Catamount Ventures was a San Francisco-based venture capital firm founded in 2000 by Jed Smith, who previously founded drugstore.com (NASDAQ: DSCM) in 1997. The firm managed four funds with over $200 million in committed capital, building a portfolio of 45-plus companies concentrated in education, healthy living, and sustainability markets. Jed Smith — who holds an MBA from Harvard Business School — positioned the firm as a hands-on partner with mission-oriented conviction, backing companies with the potential to become category leaders. Catapult is no longer making new investments and is in portfolio management mode. Catamount led rounds at the Seed through Series B stages, deploying checks of $1 million to $10 million. The portfolio achieved 15 acquisitions across its history. Notable companies include MasteryConnect, an edtech platform where Catamount led a $4.5 million Series C alongside the Chan Zuckerberg Initiative; Plum Organics, acquired by Sun-Maid in March 2021; RaiseMe; and Linden Lab, creator of Second Life. Numi Organic Tea rounded out the consumer and healthy living focus. Catamount's increasing emphasis on education within Fund IV led Jed Smith to co-found Owl Ventures, which has since grown into the world's largest edtech-focused VC with over $1 billion raised. That institutional evolution reflects the depth of Catamount's sector conviction — the firm's education thesis not only defined its later years but seeded an entirely new category-specialist fund that continues that work at scale.

Catapult Ventures is one of the most experienced venture capital fund managers in the United Kingdom, founded in 1999 and headquartered in Leicester in the Midlands. The firm has successfully managed numerous discrete venture capital funds totaling approximately £130 million on behalf of public and private sector investors, completing 151 investments across its history. Key funds include the £30 million East Midlands Regional VC Fund, the £20 million West Midlands seed fund, the £30 million Catapult Growth Fund (an Enterprise Capital Fund), and the £31 million GM&C Life Sciences Fund for Greater Manchester and Cheshire. Catapult leads rounds at the Seed through Series B stages, deploying checks of £50,000 to £2 million across healthcare, life sciences, pharmaceuticals, software, and advanced manufacturing. The firm's exit track record demonstrates consistently strong multiples: R2C Online at 12.6x, Accutronics at 9.1x, Yospace at 6.9x, Oxford Cryosystems at 5.2x, Lumora at 4.7x, and Monica Healthcare at 3.6x. Other notable exits include Abzena, Left Hand Robotics, and Ergomed. The most recent investment was Array Labs at Series A in January 2026. Catapult Ventures combined operations with Opus Ventures in 2013, deepening its regional footprint and talent base. The firm's multi-decade presence in the UK Midlands — a region often underserved by London-centric capital — reflects a deliberate focus on building enduring companies from inception through exit across the full life sciences and technology innovation cycle.

Cathay Capital is a global investment firm known for its cross-border investment strategies, supporting companies across various stages from venture to growth. Founded in 2007, the firm has established a strong global presence with offices in major cities such as Paris, New York, Shanghai, and San Francisco. With over $4.5 billion in assets under management, Cathay Capital invests across sectors including healthcare, consumer goods, digital technology, and energy, aiming to foster sustainable transformation and globalization. The firm operates through several specialized funds, such as Cathay Innovation, Cathay Health, and regional initiatives like the Seaya Cathay Latam Fund. Cathay Innovation focuses on digital transformation, investing in companies at the forefront of the tech revolution, with a portfolio that includes firms like Chime, KaiOS, and Ledger. Meanwhile, Cathay Health, a €500 million fund, targets companies at the convergence of healthcare, life sciences, and technology, helping ventures scale globally with investments in firms like Tissium and Kojin Therapeutics. Cathay Capital's strategy emphasizes connecting startups with established corporations to drive innovation and expansion, leveraging its extensive network across Europe, North America, and Asia. The firm has also launched partnerships to enhance its reach, such as the collaboration with Seaya Ventures to support Latin American startups, reflecting its commitment to fostering diverse and sustainable growth globally.